STRATA Skin Sciences
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
-1.13
Price/Sales ratio
1.78
Earnings per Share (EPS)
$-1.55

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.39-0.33-0.58-0.37-17.51-17.55-11.42-18.43-4.94-1.77-4.56-17.51
Price/Sales ratio
6.940.510.060.252.362.102.181.660.750.570.912.10
Price/Book Value ratio
0.510.580.130.362.262.321.941.961.251.511.682.32
Price/Cash Flow ratio
-0.35-1.436.041.9624.3829.8424.0533.07-24.74-37.00-24.3429.84
Price/Free Cash Flow ratio
-0.35-1.14-2.833.3862.28-118.37-800.24-23.25-5.88-3.46-7.27-7.27
Price/Earnings Growth ratio
0.00-0.040.00-0.000.180.86-1.030.46-0.04-0.010.070.86
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-439.34%25.82%60.21%57.07%57.34%64.17%61.21%66.21%60.19%55.34%54.05%64.17%
Operating Profit Margin
-1816.61%-89.07%-11.32%-7.66%-11.23%-8.21%-17.65%-14.68%-12.61%-25.79%-13.47%-8.21%
Pretax Profit Margin
-1545.90%-134.24%-9.69%-59.46%-14.39%-12.47%-17.91%-8.91%-15.17%-32.74%-20.09%-12.47%
Net Profit Margin
-1752.13%-150.90%-10.50%-68.40%-13.50%-11.99%-19.10%-9.02%-15.34%-32.46%-20.09%-11.99%
Effective Tax Rate
-47.67%-0.47%-8.27%-0.68%6.14%3.78%-6.64%-1.27%-1.14%0.84%N/A3.78%
Return on Assets
-79.88%-54.32%-7.72%-55.69%-8.48%-8.00%-9.43%-5.80%-10.61%-25.77%-15.42%-8.00%
Return On Equity
-130.59%-173.48%-22.65%-96.71%-12.90%-13.22%-17.04%-10.64%-25.41%-85.35%-35.92%-13.22%
Return on Capital Employed
-95.61%-36.94%-9.70%-7.78%-8.62%-8.67%-14.58%-13.02%-11.73%-28.83%-13.91%-8.67%
Liquidity Ratios
Current Ratio
6.401.691.751.402.691.351.31N/AN/AN/A1.301.35
Quick Ratio
4.441.151.291.002.361.171.131.280.891.050.731.17
Cash ratio
4.250.480.640.531.910.460.560.980.400.550.400.46
Days of Sales Outstanding
87.7580.2838.9636.4541.4850.6846.5341.8045.1248.5840.6850.68
Days of Inventory outstanding
390.14109.8281.3781.3680.0797.63140.35125.75140.6665.49109.8580.07
Operating Cycle
477.90190.10120.33117.82121.56148.32186.89167.55185.79114.07119.88148.32
Days of Payables Outstanding
87.64118.2853.5261.5750.5560.63112.64101.7186.8581.9067.8250.55
Cash Conversion Cycle
390.2671.8266.8056.2471.0087.6874.2565.8498.9432.16-0.0587.68
Debt Ratios
Debt Ratio
0.240.380.550.270.150.150.200.160.140.360.580.15
Debt Equity Ratio
0.401.241.610.470.230.250.370.300.351.211.390.23
Long-term Debt to Capitalization
0.280.550.590.260.18N/A0.030.220.250.540.270.18
Total Debt to Capitalization
0.280.550.610.320.190.200.270.230.260.540.270.19
Interest Coverage Ratio
-6.98N/AN/AN/AN/AN/AN/AN/AN/AN/A-16.03N/A
Cash Flow to Debt Ratio
-3.54-0.320.010.390.390.300.210.19-0.14-0.03-0.170.30
Company Equity Multiplier
1.633.192.931.731.521.651.801.832.393.312.391.52
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-19.35-0.350.010.130.090.070.090.05-0.03-0.01-0.030.07
Free Cash Flow / Operating Cash Flow Ratio
11.25-2.130.570.39-0.25-0.03-1.424.2010.673.340.39
Cash Flow Coverage Ratio
-3.54-0.320.010.390.390.300.210.19-0.14-0.03-0.170.30
Short Term Coverage Ratio
N/A-22.020.151.5011.490.300.234.74-3.12-1.47-4.250.30
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A